Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma-Reference-Cited by-同舟云学术

Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk Lymphoma

Published:2019-06 Issue: Volume:13 Page:303-309
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Delville Marianne,Touzot Fabien,Couzin Chloé,Hmitou Isabelle,Djerroudi Lounes,Ouedrani Amani,Lefrère François,Tuchman-Durand Caroline,Mollet Chloé,Fabreguettes Jean-Roch,Ferry Nicolas,Laganier Laurent,Magnani Alessandra,Magrin Elisa,Jolaine Valérie,Saez-Cirion Asier,Wolstein Orit,Symonds Geoffrey,Frange Pierre,Moins-Teisserenc Hélène,Chaix-Baudier Marie-Laure,Toubert Antoine,Larghero Jérôme,Parquet Nathalie,Brignier Anne C.,Barré-Sinoussi Françoise,Oksenhendler Eric,Cavazzana Marina

Funder

INSERM

MIGAC

CSL Behring, LLC

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference18 articles.

1. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” surveys (ANRS EN19 and Mortavic);Lewden;J. Acquir. Immune Defic. Syndr.,2008

2. Pattern of cancer risk in persons with AIDS in Italy in the HAART era;Dal Maso;Br. J. Cancer,2009

3. Stem cell transplantation for lymphoma patients with HIV infection;Michieli;Cell Transplant.,2011